Transient tumor-fibroblast interactions increase tumor cell malignancy by a TGF-b Mediated Mechanism in a Mouse Xenograft Model of Breast Cancer

PLoS ONE

Volumn 5, Issue 3, 2010, Pages

  Stuelten, Christina H ^a   Busch, Johanna I ^a   Tang, Binwu ^a   Flanders, Kathleen C ^a   Oshima, Akira ^a   Sutton, Emily ^a   Karpova, Tatiana S ^a   Roberts, Anita B ^a   Wakefield, Lalage M ^a   Niederhuber, John E ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; ARTICLE; BIOLOGICAL MODEL; BREAST TUMOR; CANCER TRANSPLANTATION; CELL MOTION; COCULTURE; CULTURE MEDIUM; CYTOLOGY; FEMALE; FIBROBLAST; HUMAN; METABOLISM; METASTASIS; MOUSE; MOUSE MUTANT; NEOPLASM; NONOBESE DIABETIC MOUSE; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; COCULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; FEMALE; FIBROBLASTS; HUMANS; MICE; MICE, INBRED NOD; MICE, SCID; MODELS, BIOLOGICAL; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; NEOPLASMS; TRANSFORMING GROWTH FACTOR BETA;

EID: 77953748064     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0009832     Document Type: Article

References (48)

1. Beacham DA, Cukierman E (2005) Stromagenesis: the changing face of fibroblastic microenvironments during tumor progression. SeminCancer Biol 15: 329-341.
2. Proia DA, Kuperwasser C (2005) Stroma: tumor agonist or antagonist. Cell Cycle 4: 1022-1025.
3. Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tlsty TD, et al. (1999) Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 59: 5002-5011.
4. Liotta LA, Kohn EC (2001) The microenvironment of the tumour-host interface. Nature 411: 375-379.
5. Baglole CJ, Ray DM, Bernstein SH, Feldon SE, Smith TJ, et al. (2006) More than structural cells, fibroblasts create and orchestrate the tumor microenvironment. ImmunolInvest 35: 297-325.
6. Micke P, Ostman A (2005) Exploring the tumour environment: cancerassociated fibroblasts as targets in cancer therapy. ExpertOpinTherTargets 9: 1217-1233.
7. Kuperwasser C, Chavarria T, Wu M, Magrane G, Gray JW, et al. (2004) Reconstruction of functionally normal and malignant human breast tissues in mice. ProcNatlAcadSciUSA 101: 4966-4971.
8. Bhowmick NA, Moses HL (2005) Tumor-stroma interactions. CurrOpinGenetDev 15: 97-101.
9. Campisi J (2005) Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 120: 513-522.
10. Orimo A, Gupta PB, Sgroi DC, Renzana-Seisdedos F, Delaunay T, et al. (2005) Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121: 335-348.
11. Egeblad M, Littlepage LE, Werb Z (2005) The fibroblastic coconspirator in cancer progression. Cold Spring HarbSympQuantBiol 70: 383-388.
12. Paszek MJ, Zahir N, Johnson KR, Lakins JN, Rozenberg GI, et al. (2005) Tensional homeostasis and the malignant phenotype. Cancer Cell 8: 241-254.
13. Massague J (2000) How cells read TGF-beta signals. NatRevMolCell Biol 1: 169-178.
14. Massague J (2008) TGFbeta in Cancer. Cell 134: 215-230.
15. Timme TL, Truong LD, Merz VW, Krebs T, Kadmon D, et al. (1994) Mesenchymal-epithelial interactions and transforming growth factor-beta expression during mouse prostate morphogenesis. Endocrinology 134: 1039-1045.
16. Bhowmick NA, Chytil A, Plieth D, Gorska AE, Dumont N, et al. (2004) TGFbeta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 303: 848-851.
17. Cheng N, Bhowmick NA, Chytil A, Gorksa AE, Brown KA, et al. (2005) Loss of TGF-beta type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-alpha-, MSP-and HGF-mediated signaling networks. Oncogene.
18. Stuelten CH, Byfield SD, Arany PR, Karpova TS, Stetler-Stevenson WG, et al. (2005) Breast cancer cells induce stromal fibroblasts to express MMP-9 via secretion of TNF-{alpha} and TGF-{beta}. JCell Sci 118: 2143-2153.
19. Goswami S, Sahai E, Wyckoff JB, Cammer M, Cox D, et al. (2005) Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/ epidermal growth factor paracrine loop. Cancer Res 65: 5278-5283.
20. Hagemann T, Wilson J, Kulbe H, Li NF, Leinster DA, et al. (2005) Macrophages induce invasiveness of epithelial cancer cells via NF-kappa B and JNK. JImmunol 175: 1197-1205.
21. Jechlinger M, Grunert S, Beug H (2002) Mechanisms in epithelial plasticity and metastasis: insights from 3D cultures and expression profiling. JMammaryGlandBiolNeoplasia 7: 415-432.
22. Kang H, Watkins G, Parr C, Douglas-Jones A, Mansel RE, et al. (2005) Stromal cell derived factor-1: its influence on invasiveness and migration of breast cancer cells in vitro, and its association with prognosis and survival in human breast cancer. Breast Cancer Res 7: R402-R410.
23. Kawai N, Tsuji S, Tsujii M, Ito T, Yasumaru M, et al. (2002) Tumor necrosis factor alpha stimulates invasion of Src-activated intestinal cells. Gastroenterology 122: 331-339.
24. Lewis MP, Lygoe KA, Nystrom ML, Anderson WP, Speight PM, et al. (2004) Tumour-derived TGF-beta1 modulates myofibroblast differentiation and promotes HGF/SF-dependent invasion of squamous carcinoma cells. BrJCancer 90: 822-832.
25. Rosen EM, Zitnik RJ, Elias JA, Bhargava MM, Wines J, et al. (1993) The interaction of HGF-SF with other cytokines in tumor invasion and angiogenesis. EXS 65: 301-310.
26. Thomas GJ, Hart IR, Speight PM, Marshall JF (2002) Binding of TGF-beta1 latency-associated peptide (LAP) to alpha(v)beta6 integrin modulates behaviour of squamous carcinoma cells. BrJCancer 87: 859-867.
27. Javelaud D, Delmas V, Moller M, Sextius P, Andre J, et al. (2005) Stable overexpression of Smad7 in human melanoma cells inhibits their tumorigenicity in vitro and in vivo. Oncogene 24: 7624-7629.
28. Wakefield LM, Roberts AB (2002) TGF-beta signaling: positive and negative effects on tumorigenesis. Curr Opin Genet Dev 12: 22-29.
29. Yamaguchi K, Shirakabe K, Shibuya H, Irie K, Oishi I, et al. (1995) Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction. Science 270: 2008-2011.
30. Kopfstein L, Christofori G (2006) Metastasis: cell-autonomous mechanisms versus contributions by the tumor microenvironment. Cell MolLife Sci 63: 449-468.
31. Nelson CM, Bissell MJ (2006) Of extracellular matrix, scaffolds, and signaling: tissue architecture regulates development, homeostasis, and cancer. AnnuRevCell DevBiol 22: 287-309.
32. Stover DG, Bierie B, Moses HL (2007) A delicate balance: TGF-beta and the tumor microenvironment. JCell Biochem 101: 851-861.
33. Liotta LA, Stetler-Stevenson WG (1990) Metalloproteinases and cancer invasion. SeminCancer Biol 1: 99-106.
34. Welch DR, Fabra A, Nakajima M (1990) Transforming growth factor beta stimulates mammary adenocarcinoma cell invasion and metastatic potential. ProcNatlAcadSciUSA 87: 7678-7682.
35. Rahimi RA, Leof EB (2007) TGF-beta signaling: a tale of two responses. JCell Biochem 102: 593-608.
36. Giehl K, Menke A (2008) Microenvironmental regulation of E-cadherinmediated adherens junctions. Front Biosci 13: 3975-3985.
37. Muller A, Homey B, Soto H, Ge N, Catron D, et al. (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature 410: 50-56.
38. Ao M, Franco OE, Park D, Raman D, Williams K, et al. (2007) Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium. Cancer Res 67: 4244-4253.
39. Mantovani A, Allavena P, Sica A, Balkwill F (2008) Cancer-related inflammation. Nature 454: 436-444.
40. Seoane J (2008) The TGFBeta pathway as a therapeutic target in cancer. ClinTranslOncol 10: 14-19.
41. Tang B, Vu M, Booker T, Santner SJ, Miller FR, et al. (2003) TGF-beta switches from tumor suppressor to prometastatic factor in a model of breast cancer progression. JClinInvest 112: 1116-1124.
42. Flanders KC, Sullivan CD, Fujii M, Sowers A, Anzano MA, et al. (2002) Mice lacking Smad3 are protected against cutaneous injury induced by ionizing radiation. AmJPathol 160: 1057-1068.
43. Tian F, DaCosta BS, Parks WT, Yoo S, Felici A, et al. (2003) Reduction in smad2/3 signaling enhances tumorigenesis but suppresses metastasis of breast cancer cell lines. Cancer Res 63: 8284-8292.
44. Stuelten CH, Kamaraju AK, Wakefield LM, Roberts AB (2007) Lentiviral reporter constructs for fluorescence tracking of the temporospatial pattern of Smad3 signaling. Biotechniques 43: 289-290, 292, 294.
45. Tian F, Byfield SD, Parks WT, Stuelten CH, Nemani D, et al. (2004) Smadbinding defective mutant of transforming growth factor beta type I receptor enhances tumorigenesis but suppresses metastasis of breast cancer cell lines. Cancer Res 64: 4523-4530.
46. van Waarde MA, van Assen AJ, Kampinga HH, Konings AW, Vujaskovic Z (1997) Quantification of transforming growth factor-beta in biological material using cells transfected with a plasminogen activator inhibitor-1 promoterluciferase construct. Anal Biochem 247: 45-51.
47. Stuelten CH, Barbul A, Busch JI, Sutton E, Katz R, et al. (2008) Acute wounds accelerate tumorigenesis by a T cell-dependent mechanism. Cancer Res 68: 7278-7282.
48. Maroulakou IG, Anver M, Garrett L, Green JE (1994) Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene. Proc Natl Acad Sci U S A 91: 11236-11240.